LINQ II Insertable Cardiac Monitor vs Vivid S60N

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

LINQ II Insertable Cardiac Monitor

by Medtronic

Vivid S60N

by GE HealthCare Technologies Inc

AI Verdict

Tool A, the Medtronic LINQ II, is an insertable cardiac monitor designed for long-term, AI-powered arrhythmia detection and remote management. In contrast, Tool B, the GE HealthCare Vivid S60N, is an AI-enhanced cardiovascular ultrasound system focused on real-time imaging, automated measurements, and workflow efficiency for assessing heart structure and function. While both leverage AI within cardiology, they address distinct diagnostic needs, making them complementary rather than directly comparable.

Choose LINQ II Insertable Cardiac Monitor if…

Choose the Medtronic LINQ II Insertable Cardiac Monitor if you require long-term, continuous monitoring for intermittent or infrequent arrhythmias that may not be captured by traditional, shorter-duration monitoring methods. Its AI-powered algorithms and remote programming capabilities are ideal for extended diagnostic periods, offering enhanced accuracy and convenience for both adult and pediatric patients.

View LINQ II Insertable Cardiac Monitor →

Choose Vivid S60N if…

Choose the GE HealthCare Vivid S60N if your clinical setting demands advanced, real-time cardiovascular ultrasound imaging with AI-powered automation for immediate diagnostic insights. This system is best suited for comprehensive cardiac assessments, enabling efficient workflows and precise quantification of heart function and valve anatomy during patient examinations.

View Vivid S60N →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	LINQ II Insertable Cardiac Monitor	Vivid S60N
Pricing	Unknown	Contact vendor for pricing
Deployment	Subcutaneous implant with remote monitoring via mobile app or home communicator.	On-premise (physical medical device)
FDA Status	Cleared AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

LINQ II Insertable Cardiac Monitor

The Medtronic LINQ II offers superior patient usability through its long-term, passive monitoring and remote data transmission via a mobile app or home communicator, minimizing active patient involvement. For clinicians, the remote programming capability enhances convenience and efficiency in managing the device. This contrasts with the active, in-clinic nature of an ultrasound scan.

Clinical Value

LINQ II Insertable Cardiac Monitor

While both tools offer high clinical value, the LINQ II's ability to provide continuous, long-term heart rhythm monitoring with AI-powered accuracy is critical for diagnosing intermittent arrhythmias that might otherwise be missed by episodic testing. This extended diagnostic window provides a unique and often profound clinical advantage for specific patient populations.

Pricing & Value

Tie

Both the LINQ II and Vivid S60N operate with non-transparent, enterprise-negotiated pricing models, which is typical for advanced medical devices. Neither product publicly discloses specific pricing details or offers a free trial, making a direct comparison of their cost-effectiveness and overall value proposition impossible without further information.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

The LINQ II explicitly targets 'Solo to large health systems' and boasts over a million patients worldwide, demonstrating proven scalability and adoption across diverse healthcare environments. Its hybrid deployment model and remote management capabilities offer flexibility for large-scale patient monitoring, while the Vivid S60N, though integrating with standard hospital IT, is an on-premise physical device.

Innovation

LINQ II Insertable Cardiac Monitor

The LINQ II showcases significant innovation with its AccuRhythmu2122 AI algorithms for enhanced arrhythmia detection accuracy, remote programming for an implanted device, and an impressive 4.5 years of continuous monitoring. These features represent substantial advancements in long-term, passive cardiac diagnostics.

Support & Docs

Tie

Both Medtronic and GE HealthCare are global leaders in the medical device industry, implying robust support and documentation infrastructures. However, the provided facts do not offer specific details regarding the scope, quality, or availability of their support services or documentation for either product, making a definitive distinction between them impossible.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	LINQ II Insertable Cardiac Monitor	Vivid S60N
Product Name	LINQ II Insertable Cardiac Monitor	Vivid S60N
Product Type/Description Summary	Advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias.	Advanced cardiovascular ultrasound systems featuring AI-powered imaging, automated measurements, and workflow enhancements for confident diagnosis and efficient patient care.
Primary Categories	Cardiology AI, Clinical Decision Support & Reference	Cardiology AI
Key AI-Powered Feature	AccuRhythmu2122 AI algorithms for enhanced accuracy, Innovative PVC detection algorithm	AI-enabled automation for measurements and workflow
Target Specialties	Cardiology	Cardiology, Pediatrics, Radiology

Videos

Demos, reviews, and walkthroughs featuring LINQ II Insertable Cardiac Monitor and Vivid S60N.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the fundamental differences in the clinical applications and diagnostic capabilities of the LINQ II Insertable Cardiac Monitor and the Vivid S60N Ultrasound System?

The LINQ II is an insertable cardiac monitor designed for long-term, continuous heart rhythm monitoring to diagnose arrhythmias, offering up to 4.5 years of monitoring. In contrast, the Vivid S60N is an advanced cardiovascular ultrasound system that provides real-time imaging, automated measurements, and workflow enhancements for diagnosing heart function and anatomy.

How do the AI capabilities of each tool specifically contribute to patient care or workflow efficiency?

The LINQ II utilizes AccuRhythmu2122 AI algorithms to enhance the accuracy of arrhythmia detection and diagnosis, including an innovative PVC detection algorithm, and can reduce false alerts. The Vivid S60N employs AI-enabled automation for measurements and workflow, such as automated Doppler measurements and LV ejection fraction, to streamline cardiovascular ultrasound examinations and improve efficiency.

What are the key differences in how these tools handle patient data and integrate into existing hospital IT systems?

The LINQ II offers a hybrid deployment and transmits data via the MyCareLink Heartu2122 mobile app or MyCareLink Relayu2122 home communicator, operating within a HIPAA-compliant framework. The Vivid S60N is an on-premise physical medical device with DICOMu00ae connectivity for seamless integration with reporting systems, PACS, and EMRs, handling protected health information (PHI) within a HIPAA-regulated environment.

Are both the LINQ II and the Vivid S60N suitable for use in pediatric patients?

Yes, the LINQ II has received FDA clearance for use in pediatric patients aged 2 and older who have heart rhythm abnormalities and require long-term, continuous monitoring. The Vivid S60N is also indicated for pediatric cardiac imaging and supports pediatric applications.

What features do these tools offer for remote patient monitoring or engagement outside of the clinic setting?

The LINQ II provides remote programming capability and utilizes the MyCareLink Heartu2122 mobile app for data transmission and the MyCareLink Relayu2122 home communicator option, enabling continuous monitoring and data transfer from the patient's home. The Vivid S60N, as an on-premise ultrasound system, does not offer remote patient monitoring features in the same context as an implantable device, but GE HealthCare does offer remote collaboration and management solutions for other ultrasound devices.

Are there any specific considerations regarding MRI compatibility for patients utilizing these devices?

Yes, the LINQ II Insertable Cardiac Monitor is MRI compatible for both 1.5 and 3.0T scans. As the Vivid S60N is an external ultrasound system, MRI compatibility is not a direct concern for the device itself, but rather for the patient if they have other implantable devices.